The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth.

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.